[1]Shi FT，Wang QF.Expression of the inhibitor of apoptosis protein livin and tumor metastasis associated gene in lung cancer and its relationship with clinical features of lung cancer［J］.Oncology Progress，2017，15(7)：794-797.［史芳涛，王庆锋.凋亡抑制蛋白基因Livin及肿瘤转移相关基因在肺癌组织中的表达及其与肺癌临床特征的关系分析［J］.癌症进展，2017，15(7)：794-797.］
[2]Lin JH，Deng G，Huang Q，et al.KIAP，a novel member of the inhibitor of apoptosis protein family［J］.Biochem Biophys Res Commun，2000，279(3)：820-831.
[3]Barton BE，Karras JG，Murphy TF，et al.Signal transducer and activator of transcription3(stst3)activation in prostate cancer：Direct Stat3 inhibition induces apoptosis in prostate cancer lines［J］.Mol Cancer Ther，2013，13(5)：11-20.
[4]Garcia R，Bowman TL，Niu G，et al.Constitutive activation of Stat3 by the Sre and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells［J］.Oncogene，2001，20(20)：2499-2513.
[5]Kasof GM，Gomes BC.Livin，a novel inhibitor of apoptosis protein family member［J］.Biol Chem，2001，276(5)：3238-3246.
[6]Chen YS，Huang LP，Li HR，et al.Expressions and clinical significances of SDF-I，CXCR4 and Livin in lung cancer［J］.International Journal of Respiration，2013，33(8)：570-571.［陈愉生，黄丽萍，李鸿茹，等.SDF-1、CXCR4在肺癌组织中的表达及其与凋亡抑制蛋白基因Livin的相关性初步探讨［J］.国际呼吸杂志，2013，33(8)：570-571.］
[7]Liu J，Bai X，Li YX，et al.Significance of GPRC5A and STAT3 expression in esophageal squamous cell carcinoma［J］.World Chinese Journal of Digestology，2014，22(31)：4810-4815.
[8]Sun ZG，Wang Z.Research advances of STAT3 and primary esophageal squamous cell cancer［J］.Chinese Journal of Cancer Prevention and Treatment，2010，10(17)：786-789.［孙志钢，王洲.STAT3与原发性食管鳞癌关系的研究进展［J］.中华肿瘤防治杂志，2010，10(17)：786-789.］
[9]Wang X，Crowe PJ，Goldstein D，et al.STAT3 inhibition，a novel approach to enhancing targeted therapy in human cancers（review)［J］.International Journal of Oncology，2012，41(4)：1181-1191.
[10]Zhang H，Zhao M，Zhou Y，et al.Changes and significance of Stat3 expression in lung cancer［J］.Shandong Medical Journal，2015，55(25)：54-55.［ 张辉，赵敏，周颖，等.肺癌组织中Stat3的表达变化及意义［J］.山东医药，2015，55(25)：54-55.］
[11]Zhu PC，Sun ZG，Xiao W.Relationship between STAT3 signaling pathway and its target gene VEGF，VEGF-C in patients with non-small cell lung cancer［J］.Chinese Journal of Cancer Prevention and Treatment，2016，23(12)：35-37.［朱鹏冲，孙志钢，肖伟.非小细胞肺癌组织STAT3信号与靶基因VEGF及VEGF-C关系的研究［J］.中华肿瘤防治杂志，2016，23(12)：35-37.］
[12]Dong Qiuxia，Pan Xianying，Shang Chuanxiang，et al.Expression and significance of PD-L1 and p-STAT3 protein in patients with lung adenocarcinoma［J］.Modern Oncology，2017，25(24)：4003-4006.［董秋霞，潘贤英，尚春香，等.PD-L1和P-STAT3蛋白在肺腺癌术后组织中的表达及临床意义［J］.现代肿瘤医学，2017，25(24)：4003-4006.］
[13]Han AJ，Zong YS，He JH，et al.Expression characteristic of Stat3 and its relation to the expression of Bcl-2 and LMP1 in nasopharyngeal carcinoma［J］.Chin J Cancer Prev Treat，2013，12(2)：81-84.
[14]Yu GT，Bu LL，Zhao YY，et al.Inhibition of mTOR reduce Stat3 and PAI related angiogenesis in salivary gland adenoid cystic carcinoma［J］.Am J Cancer Res，2014，4(6)：764-775.
[15]Reinecke K，Eminel S，Dierck F，et al.The JNK inhibitor XG-102 protects against TNBS-induced colitis［J］.PLoS One，2012，7(3)：e30985.
[16]Nishihara H，Kizaka Kondoh，Insel PA，et al.Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein（IAP)-2［J］.Proc Natl Acad Sci USA，2003，100(15)：8921-8926.